Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Seps Pharma

Seps Pharma
2007 FOUNDED
M&A STATUS
1-10 EMPLOYEES
Buyout/LBO LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Provider of pharmaceutical services. The company provides drug product development services to the pharmaceutical and biotechnology companies in Europe and Japan.

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Drug Delivery
Other Industries
Pharmaceuticals
Drug Discovery
Primary Office
  • Technologiepark 4
  • 9052 Ghent
  • Belgium

+32 09 000 00 00

Seps Pharma Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Seps Pharma‘s full profile, request access.

Request full access to PitchBook

Seps Pharma Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
0000000 0000000000 Private Debt Financed West Columbia, SC 000 00000 000000000 00000
To view this company’s complete list of competitors, request access »

Seps Pharma Executive Team (3)

Name Title Board
Seat
Contact
Info
Yves Gonnissen Ph.D Managing Director, Co-Founder, Board of Director & Chief Executive Officer
Jody Voorspoels Ph.D Chief Scientific Officer & Director
Andre Remans Chairman & Co-Founder

Seps Pharma Board Members (5)

Name Representing Role Since Contact
Info
00000 000000 Seps Pharma Chairman & Co-Founder 000 0000
000 0000000 00 Self Board Member 000 0000
00000 00000 Self Director 000 0000
0000 0000000 Self Director 000 0000
0000 000000000000 Self Director 000 0000